CL2007002971A1 - Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras. - Google Patents

Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras.

Info

Publication number: CL2007002971A1
Authority: CL; Chile
Prior art keywords: aminometil; imidazol; anxiety; pharmaceutical composition; bipolar disorder
Prior art date: 2006-10-19

Application number

CL200702971A

Other languages

English (en)

Inventor

Galley Annick Goerger Ka Guido

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-19

Filing date

2007-10-17

Publication date

2008-05-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38876376&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2007002971(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-10-17 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2008-05-30 Publication of CL2007002971A1 publication Critical patent/CL2007002971A1/es

Links

208000019901 Anxiety disease Diseases 0.000 title 1
208000020925 Bipolar disease Diseases 0.000 title 1
230000036506 anxiety Effects 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

CL200702971A 2006-10-19 2007-10-17 Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras. CL2007002971A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP06122586		2006-10-19

Publications (1)

Publication Number	Publication Date
CL2007002971A1 true CL2007002971A1 (es)	2008-05-30

Family

ID=38876376

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL200702971A CL2007002971A1 (es)	2006-10-19	2007-10-17	Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras.

Country Status (20)

Country	Link
US (1)	US8586617B2 (es)
EP (1)	EP2076497B1 (es)
JP (2)	JP5335681B2 (es)
KR (1)	KR101176699B1 (es)
CN (1)	CN101528710B (es)
AR (1)	AR063327A1 (es)
AT (1)	ATE546437T1 (es)
AU (1)	AU2007312390B2 (es)
BR (1)	BRPI0717939A2 (es)
CA (1)	CA2666762C (es)
CL (1)	CL2007002971A1 (es)
ES (1)	ES2381589T3 (es)
IL (1)	IL197877A (es)
MX (1)	MX2009003801A (es)
NO (1)	NO20091478L (es)
PE (1)	PE20080889A1 (es)
RU (1)	RU2009112496A (es)
TW (1)	TW200833685A (es)
WO (1)	WO2008046757A1 (es)
ZA (1)	ZA200902278B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101176699B1 (ko)	2006-10-19	2012-08-23	에프. 호프만-라 로슈 아게	아미노메틸-4-이미다졸
CA2666489C (en) *	2006-10-19	2012-10-02	F. Hoffmann-La Roche Ag	Imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors for diabetes
DK2562162T3 (en) *	2008-01-22	2015-11-23	Dow Agrosciences Llc	N-cyano-4-amino-5-fluoro-pyrimidine derivatives as fungicides
US8242153B2 (en) *	2008-07-24	2012-08-14	Hoffmann-La Roche Inc.	4,5-dihydro-oxazol-2YL derivatives
PL2317851T3 (pl) *	2008-08-01	2014-06-30	Dow Agrosciences Llc	Zastosowanie 5-fluorocytozyny jako fungicydu
JP5539518B2 (ja)	2009-08-14	2014-07-02	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	２−アミノ−５−トリフルオロメチルピリミジン誘導体の位置選択的調製
US8933227B2 (en) *	2009-08-14	2015-01-13	Boehringer Ingelheim International Gmbh	Selective synthesis of functionalized pyrimidines
US8354441B2 (en) *	2009-11-11	2013-01-15	Hoffmann-La Roche Inc.	Oxazoline derivatives
US9452980B2 (en)	2009-12-22	2016-09-27	Hoffmann-La Roche Inc.	Substituted benzamides
AU2011258217B2 (en) *	2010-05-26	2016-12-15	Sunovion Pharmaceuticals Inc.	Heteroaryl compounds and methods of use thereof
KR101651208B1 (ko)	2014-02-19	2016-08-26	충북대학교 산학협력단	클로로겐산 유도체 화합물 및 이를 유효성분으로 포함하는 항염증 및 피부미백용 조성물
WO2017001936A2 (en) *	2015-07-01	2017-01-05	Lifesci Pharmaceuticals, Inc.	Therapeutic inhibitory compounds
WO2017132912A1 (zh) *	2016-02-03	2017-08-10	华东理工大学	苯并脂肪环取代烷基胺类化合物及其用途
MA53755A (fr)	2016-03-17	2021-08-04	Hoffmann La Roche	Dérivé de 5-éthyl-4-méthyl-pyrazole-3-carboxamide ayant une activité comme agonist de taar
WO2017190050A1 (en) *	2016-04-28	2017-11-02	Cornell University	Inhibitors of soluble adenylyl cyclase
EP3463359A4 (en) *	2016-06-02	2020-08-26	Purdue Pharma LP	SPURENAMINE-ASSOCIATED RECEPTOR-1 AGONISTS AND PARTIAL AGONISTS FOR PAIN MANAGEMENT
WO2023033679A1 (en)	2021-09-01	2023-03-09	Limited Liability Company «Excellena Research And Development» (Llc «Excellena»)	(azacycloalkyl)methoxy-substituted benzamides as modulators of trace amine-associated receptor 1 (taar1)
WO2023033680A1 (en)	2021-09-01	2023-03-09	Limited Liability Company «Excellena Research And Development» (Llc «Excellena»)	Substituted 2,3,4,5-tetrahydrobenzo[ f][1,4]oxazepines as modulators of trace amine-associated receptor 1 (taar1)
WO2023033681A1 (en)	2021-09-01	2023-03-09	Limited Liability Company «Excellena Research And Development» (Llc «Excellena»)	Substituted 2-(5-aryl-4 h-1,2,4-triazol-3-yl)ethanamines as modulators of trace amine-associated receptor 1 (taar1)

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2731471A (en)		1956-01-17		Nxg hi
FR6551E (fr)	1905-07-27	1906-12-17	Carlo Chiesa	Séchoir à tambour rotatif, démontable et transportable, et fonctionnant à ciel ouvert, pour cocons, céréales, etc.
US2161938A (en)	1934-07-31	1939-06-13	Soc Of Chemical Ind	Imidazolines
US2457047A (en)	1946-02-13	1948-12-21	Monsanto Chemicals	2-(2'-thenyl)-4, 5-dihydroimidazoles and process for making the same
US2778836A (en)	1954-04-02	1957-01-22	Union Chimique Belge Sa	Substituted 2-methyl-delta2 imidazolines
US2744910A (en)	1955-06-27	1956-05-08	Bristol Lab Inc	2-(ortho-benzylbenzyl)-imidazoline and acid addition salts
US2744909A (en)	1955-06-27	1956-05-08	Bristol Lab Inc	2-(ortho-phenylbenzyl) imidazoline and acid addition salts
US2919274A (en)	1957-09-17	1959-12-29	Sahyun Melville	Amidines
GB877306A (en)	1958-04-21	1961-09-13	Pfizer & Co C	Halogenated derivatives of tetrahydro-1-naphthyl cyclic amidines
DE1121054B (de)	1960-11-23	1962-01-04	Merck Ag E	Verfahren zur Herstellung eines neuen Imidazolinderivates und dessen Saeureadditionssalzen
US3202660A (en)	1961-10-09	1965-08-24	Boehringer Sohn Ingelheim	Process for the preparation of 3-arylamino-1, 3-diazacycloalkenes
DE1150180B (de)	1962-04-12	1963-06-12	Merck Ag E	Mittel zur Vorbehandlung der Haut fuer die Rasur
ES323985A1 (es)	1966-02-26	1966-12-16	Blade Pique Juan	Procedimiento para la obtenciën de derivados del imidazol
US3377247A (en)	1967-04-28	1968-04-09	Dow Chemical Co	Antidepressant method
US3586695A (en)	1968-01-26	1971-06-22	Dow Chemical Co	Substituted imidazolinyl indoles
BE754935A (fr)	1969-08-13	1971-02-17	Hoechst Ag	2-(thienyl-3'-amino)-1,3-diazacycloalcenes et leur preparation
US3818094A (en)	1969-08-28	1974-06-18	Boehringer Sohn Ingelheim	Hypotensive pharmaceutical compositions containing certain 2-anilino-1,3-diazacyclopentenes-(2)
US3622579A (en)	1969-08-28	1971-11-23	Boehringer Sohn Ingelheim	Derivatives of 2-anilino-1,3-diazacyclopentene-(2)
US3660423A (en)	1970-02-13	1972-05-02	Dow Chemical Co	2-(substituted benzyl)methyl-2-imidazolines
GB1333471A (en)	1971-01-27	1973-10-10	Labaz	Imidazoline derivatives and process for preparing the same
US4125620A (en)	1974-10-01	1978-11-14	Boehringer Ingelheim Gmbh	2-[(2',6'-Disubstituted-phenyl)-imino]-imidazolidines and salts thereof
US3992403A (en)	1975-05-30	1976-11-16	Schering Corporation	2-Imidazolines and their use as hypoglycemic agents
GB1538097A (en)	1976-01-26	1979-01-10	Lafon Labor	Substituted phenyl-amidines
US4323570A (en)	1978-11-15	1982-04-06	Beiersdorf Aktiengesellschaft	Substituted aminopyrimidines
AU518569B2 (en)	1979-08-07	1981-10-08	Farmos-Yhtyma Oy	4-benzyl- and 4-benzoyl imidazole derivatives
GB2110663B (en) *	1981-12-04	1985-08-07	Farmos Group Ltd	Imidazole derivatives
US4505918A (en) *	1982-11-08	1985-03-19	Merck & Co., Inc.	4-[2-Pyridinylthio(oxy or amino)methyl]-1H-imidazoles and derivatives
US4540705A (en)	1983-03-14	1985-09-10	Sterling Drug Inc.	Antidepressant imidazolines and related compounds
EP0166937B1 (en)	1984-06-06	1991-08-28	Abbott Laboratories	Adrenergic compounds
US4665095A (en)	1985-12-11	1987-05-12	Abbott Laboratories	Use of 2-[(3,5-dihalo-4-aminobenzyl)]imidazolines to stimulate alpha-1 adrenergic receptors and to treat nasal congestion
JPH0774205B2 (ja) *	1986-12-04	1995-08-09	三井石油化学工業株式会社	新規イミダゾ−ル誘導体
GB2215206B (en)	1988-02-29	1991-07-03	Farmos Oy	4-substituted imidazole derivatives useful in perioperative care
FI894911A0 (fi)	1989-10-17	1989-10-17	Farmos Oy	En terapeutiskt vaerdefull foerening.
FR2692893B1 (fr) *	1992-06-24	1994-09-02	Sanofi Elf	Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
DE69534283T2 (de)	1993-10-13	2006-03-16	Horacek, H. Joseph	Clonidinhaltiges arzneimittel mit verzögerter wirkstoffabgabe
GB9425211D0 (en)	1994-12-14	1995-02-15	Ucb Sa	Substituted 1H-imidazoles
US5610174A (en)	1995-06-02	1997-03-11	Synaptic Pharmaceutical Corporation	Use of α1A -selective adrenoceptor agonists for the treatment of urinary incontinence
GB9520150D0 (en)	1995-10-03	1995-12-06	Orion Yhtymae Oy	New imidazole derivatives
DE19607487C2 (de)	1996-02-28	1998-09-10	Byk Gulden Lomberg Chem Fab	Verwendung von alpha1-Adrenoceptor-Antagonisten
US5969137A (en)	1996-09-19	1999-10-19	Virginia Commonwealth University	Benzylamidine derivatives with serotonin receptor binding activity
IL123232A0 (en)	1997-02-11	1999-11-30	Lilly Co Eli	Medicament for inhibiting glucose metabolism deterioration
US5866579A (en)	1997-04-11	1999-02-02	Synaptic Pharmaceutical Corporation	Imidazole and imidazoline derivatives and uses thereof
HUP0004557A3 (en)	1997-12-04	2002-03-28	Allergan Inc Irvine	Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors and pharmaceuticals containing the same
US6841684B2 (en)	1997-12-04	2005-01-11	Allergan, Inc.	Imidiazoles having reduced side effects
ES2198033T3 (es)	1997-12-19	2004-01-16	Eli Lilly And Company	Compuestos de imidazolina hipoglucemicos.
ATE293102T1 (de)	1998-04-23	2005-04-15	Takeda Pharmaceutical	Naphthalene derivate ,ihre herstellung und verwendung
ES2150378B1 (es)	1998-08-07	2001-07-01	Esteve Labor Dr	Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de los trastornos mediados por un exceso de substancia p.
CA2246027A1 (en)	1998-08-27	2000-02-27	Virginia Commonwealth University	Benzylamidine derivatives with serotonin receptor binding activity
PE20010781A1 (es)	1999-10-22	2001-08-08	Takeda Chemical Industries Ltd	Compuestos 1-(1h-imidazol-4-il)-1-(naftil-2-sustituido)etanol, su produccion y utilizacion
FI20000073A0 (fi)	2000-01-14	2000-01-14	Orion Yhtymae Oy	Uusia imidatsolijohdannaisia
JP2001302643A (ja)	2000-04-21	2001-10-31	Suntory Ltd	環状アミジン化合物
EP1319070A2 (en)	2000-09-12	2003-06-18	Oregon Health & Science University	Mammalian receptor genes and uses
IL155436A0 (en)	2000-11-14	2003-11-23	Hoffmann La Roche	Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists
IL147921A0 (en)	2002-01-31	2002-08-14	Abdulrazik Mohammad	A method for treating central nervous system disorders by ocular dosing
TW200930291A (en)	2002-04-29	2009-07-16	Bayer Cropscience Ag	Pesticidal heterocycles
KR100492252B1 (ko)	2002-08-09	2005-05-30	한국화학연구원	이미다졸을 포함하는 이차아민으로 치환된 벤조피란유도체 및 그의 제조방법
WO2004018419A2 (en) *	2002-08-23	2004-03-04	Chiron Corporation	Benzimidazole quinolinones and uses thereof
MXPA05002571A (es) *	2002-09-04	2005-09-08	Schering Corp	Pirazolopirimidinas como inhibidores de cinasa dependientes de ciclina.
AU2003278249B8 (en)	2002-09-05	2010-11-18	Aventis Pharma S.A.	Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same
AU2006242109A1 (en) *	2005-05-03	2006-11-09	Bayer Cropscience Ag	Insecticidal substituted aminoalkyl heterocyclic and heteroaryl derivatives
US20090170907A1 (en) *	2005-06-06	2009-07-02	Smithkline Beecham Corporation	Chemical Compounds
US7803828B2 (en)	2005-08-25	2010-09-28	Schering-Plough Corporation	Functionally selective alpha2C adrenoreceptor agonists
EP2311814A1 (en)	2005-12-01	2011-04-20	F. Hoffmann-La Roche AG	2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between P53 and MDM2 proteins for use as anticancer agents
NL2000439C2 (nl)	2006-01-20	2009-03-16	Quark Biotech	Therapeutische toepassingen van inhibitoren van RTP801.
RU2008130448A (ru) *	2006-01-27	2010-03-10	Ф. Хоффманн-Ля Рош Аг (Ch)	Применение производных 4-имидазола для расстройств цнс
CL2007002994A1 (es)	2006-10-19	2008-02-08	Wyeth Corp	Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
ATE462696T1 (de)	2006-10-19	2010-04-15	Hoffmann La Roche	Aminomethyl-2-imidazole mit affinität zu mit dem trace-amin assoziierten rezeptoren
CA2666489C (en)	2006-10-19	2012-10-02	F. Hoffmann-La Roche Ag	Imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors for diabetes
KR101176699B1 (ko) *	2006-10-19	2012-08-23	에프. 호프만-라 로슈 아게	아미노메틸-4-이미다졸

2007
- 2007-10-09 KR KR1020097007948A patent/KR101176699B1/ko not_active IP Right Cessation
- 2007-10-09 CN CN2007800388091A patent/CN101528710B/zh not_active Expired - Fee Related
- 2007-10-09 AU AU2007312390A patent/AU2007312390B2/en not_active Ceased
- 2007-10-09 MX MX2009003801A patent/MX2009003801A/es active IP Right Grant
- 2007-10-09 JP JP2009532767A patent/JP5335681B2/ja not_active Expired - Fee Related
- 2007-10-09 ES ES07821039T patent/ES2381589T3/es active Active
- 2007-10-09 CA CA2666762A patent/CA2666762C/en not_active Expired - Fee Related
- 2007-10-09 AT AT07821039T patent/ATE546437T1/de active
- 2007-10-09 WO PCT/EP2007/060666 patent/WO2008046757A1/en active Application Filing
- 2007-10-09 RU RU2009112496/04A patent/RU2009112496A/ru not_active Application Discontinuation
- 2007-10-09 EP EP07821039A patent/EP2076497B1/en not_active Not-in-force
- 2007-10-09 BR BRPI0717939-1A2A patent/BRPI0717939A2/pt not_active IP Right Cessation
- 2007-10-15 US US11/872,203 patent/US8586617B2/en not_active Expired - Fee Related
- 2007-10-17 TW TW096138932A patent/TW200833685A/zh unknown
- 2007-10-17 PE PE2007001403A patent/PE20080889A1/es not_active Application Discontinuation
- 2007-10-17 CL CL200702971A patent/CL2007002971A1/es unknown
- 2007-10-17 AR ARP070104590A patent/AR063327A1/es unknown
2009
- 2009-03-26 IL IL197877A patent/IL197877A/en not_active IP Right Cessation
- 2009-04-01 ZA ZA200902278A patent/ZA200902278B/xx unknown
- 2009-04-17 NO NO20091478A patent/NO20091478L/no not_active Application Discontinuation
2013
- 2013-05-02 JP JP2013096834A patent/JP5567177B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU2007312390A1 (en)	2008-04-24
ATE546437T1 (de)	2012-03-15
AU2007312390B2 (en)	2013-03-28
ZA200902278B (en)	2010-03-31
JP2010506875A (ja)	2010-03-04
JP5335681B2 (ja)	2013-11-06
CA2666762A1 (en)	2008-04-24
CN101528710A (zh)	2009-09-09
MX2009003801A (es)	2009-04-22
US8586617B2 (en)	2013-11-19
BRPI0717939A2 (pt)	2013-12-03
WO2008046757A1 (en)	2008-04-24
KR20090055035A (ko)	2009-06-01
EP2076497A1 (en)	2009-07-08
JP5567177B2 (ja)	2014-08-06
PE20080889A1 (es)	2008-06-27
US20080119535A1 (en)	2008-05-22
CN101528710B (zh)	2012-11-07
TW200833685A (en)	2008-08-16
EP2076497B1 (en)	2012-02-22
IL197877A (en)	2015-07-30
ES2381589T3 (es)	2012-05-29
JP2013173779A (ja)	2013-09-05
NO20091478L (no)	2009-05-05
KR101176699B1 (ko)	2012-08-23
CA2666762C (en)	2014-12-30
AR063327A1 (es)	2009-01-21
RU2009112496A (ru)	2010-11-27
IL197877A0 (en)	2009-12-24

Publication	Publication Date	Title
CL2007002971A1 (es)	2008-05-30	Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras.
CL2007002970A1 (es)	2008-05-30	Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras.
CO6321189A2 (es)	2011-09-20	Compuestos de tiazol y oxazol de bencen-sulfonamida
CL2008000703A1 (es)	2008-09-26	Compuestos derivados de pirimidinas sustituidas; procedimiento para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar transtornos hematologicos.
CL2007003832A1 (es)	2008-07-25	Compuestos derivados de azaespiro; procedimiento de preparacion; composicion farmaceutica; y su uso para prevenir y tratar ansiedad, trastornos depresivos, entre otras enfermedades.
NI201000055A (es)	2010-08-13	2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
CL2007002635A1 (es)	2009-10-23	Compuestos derivados de quinazolinona e isoquinolinona, moduladores de la actividad del eje hpa; composicion farmaceutica que los comprende; y su uso en el tratamiento y/o prevencion relacionado con estres o depresion.
ECSP10010548A (es)	2010-11-30	Composiciones y metodos de preparacion y uso de las mismas
CL2011000527A1 (es)	2011-08-12	Compuestos derivados de benzofurano; composicion farmaceutica que los comprende;y su uso en el tratamiento de la hepatitis c.
CL2008002076A1 (es)	2009-01-30	Compuestos derivados de ariloxazoles sustituidos; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar diabetes, sindrome metabolico, dislipidemias, entre otras enfermedades.
BRPI0814593A2 (pt)	2015-01-20	Composto, composição farmacêutica que o contém e uso do composto.
CL2007003005A1 (es)	2008-05-23	Compuestos derivados de [1,6]-naftiridinona, moduladores de la actividad cinasa; composicion farmaceutica que los comprende; y su uso para tratar trastornos proliferativos, inflamatorios, autoinmune, del sistema nervioso central, entre otros.
UY30319A1 (es)	2008-01-02	Formulaciones de inhibidores de dpp iv
CL2008002319A1 (es)	2009-01-02	Compuestos derivados de pirrolopirimidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer.
CL2007003226A1 (es)	2008-02-08	Compuestos derivados de piridinona; composicion farmaceutica; y uso para tratar el cancer.
CL2007002377A1 (es)	2008-04-04	Compuestos derivados de quinazolina; procedimiento de preparacion; composicion farmaceutica; y su uso como anticancerigeno.
CL2008002430A1 (es)	2009-10-16	Compuestos derivados de bencenosulfonamida, inhibidores de catepsina c; composicion farmaceutica que los comprende; y su uso para el tratamiento de la epoc.
CL2009001484A1 (es)	2009-12-04	Sal glicinato de metformina; composición farmacéutica que comprende la sal; y su uso para tratar la hiperglicemia.
CL2007002021A1 (es)	2008-02-08	Compuestos derivados de oxoisoindol; composicion farmaceutica que los comprende; y su uso para tratar arritmias.
CL2007001976A1 (es)	2008-05-16	Compuestos derivados de dioxoalcanos y dioxoalquenos; procedimiento de preparacion; composicion farmaceutica; y su uso para tratar asma, tos, purito, hipersensibilidad.
CR9786A (es)	2008-05-22	Compuestos de bencimidazol-tiofeno
CL2008002041A1 (es)	2009-01-09	Compuestos derivados de piperidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar ansiedad.
CL2008002726A1 (es)	2008-10-10	Compuestos derivados de isoquinolinilo e isoindolinilo, antagonistas de histamina-3; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar trastornos del sistema nervioso c
UY32659A (es)	2010-12-31	Pirazinilpirazoles
CL2009001298A1 (es)	2009-12-28	Compuestos derivados de n-ciclohexil-2-fenoxinicotinamida; composición farmcéutica que los comprende; combinación farmacéutica que los comprende; y su uso para tratar una enfermedad mediada por la pde4.